Rubidium rb-82
Cardiogen, Ruby-fill (rubidium rb-82) is a small molecule pharmaceutical. Rubidium rb-82 was first approved as Cardiogen-82 on 1989-12-29.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Cardiogen, Ruby-fill
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| ruby-fill | New Drug Application | 2020-10-20 |
| cardiogen-82 | New Drug Application | 2021-01-01 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
Code | Description |
|---|---|
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries |
Clinical
Clinical Trials
193 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 6 | 2 | 29 | 26 | 15 | 78 |
| Insulin resistance | D007333 | EFO_0002614 | 2 | 5 | 4 | 4 | 7 | 20 | |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.81 | 1 | 4 | 1 | 4 | 1 | 10 |
| Glucose intolerance | D018149 | HP_0000833 | R73.03 | — | 1 | 6 | 2 | 1 | 10 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | 1 | 3 | 1 | 2 | 7 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | 1 | — | 2 | 2 | 5 |
| Fatty liver | D005234 | — | — | — | 1 | 1 | 2 | ||
| Hypertension | D006973 | EFO_0000537 | I10 | — | — | 1 | 1 | — | 2 |
| Coronary artery disease | D003324 | I25.1 | — | — | 1 | 1 | — | 2 | |
| Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | — | — | — | 1 | 1 | 2 |
Show 9 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 3 | 4 | 4 | — | 1 | 12 |
| Asthma | D001249 | EFO_0000270 | J45 | 1 | 2 | 1 | — | — | 3 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | 2 | — | 1 | 3 |
| Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | — | 2 | — | 1 | 3 |
| Hyperlipidemias | D006949 | EFO_0003774 | E78.5 | — | 1 | 1 | — | — | 2 |
| Glucose metabolism disorders | D044882 | — | — | 2 | — | — | 2 | ||
| Chronic renal insufficiency | D051436 | N18 | — | 1 | 2 | — | — | 2 | |
| Endometriosis | D004715 | EFO_0001065 | N80 | — | 2 | 1 | — | — | 2 |
| Dyslipidemias | D050171 | HP_0003119 | — | — | 1 | — | — | 1 | |
| Prediabetic state | D011236 | EFO_1001121 | R73.03 | — | — | 1 | — | — | 1 |
Show 6 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hiv infections | D015658 | EFO_0000764 | B20 | 4 | 3 | — | — | 4 | 10 |
| Hyperinsulinism | D006946 | HP_0000842 | E16.1 | — | 1 | — | — | 1 | 2 |
| Ulcerative colitis | D003093 | EFO_0000729 | K51 | 1 | 2 | — | — | — | 2 |
| Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | 1 | — | — | — | 1 |
| Non-small-cell lung carcinoma | D002289 | — | 1 | — | — | — | 1 | ||
| Squamous cell carcinoma of head and neck | D000077195 | — | 1 | — | — | — | 1 | ||
| Melanoma | D008545 | — | 1 | — | — | — | 1 | ||
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | 1 | — | — | — | 1 |
| Adenocarcinoma | D000230 | — | 1 | — | — | — | 1 | ||
| Sezary syndrome | D012751 | C84.1 | — | 1 | — | — | — | 1 |
Show 15 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | 4 | — | — | — | 2 | 6 | ||
| Malaria | D008288 | EFO_0001068 | B54 | 1 | — | — | — | 1 | 2 |
| Lipodystrophy | D008060 | E88.1 | 1 | — | — | — | 1 | 2 | |
| Renal cell carcinoma | D002292 | 1 | — | — | — | — | 1 | ||
| Papillary thyroid cancer | D000077273 | 1 | — | — | — | — | 1 | ||
| Follicular adenocarcinoma | D018263 | 1 | — | — | — | — | 1 | ||
| Drug interactions | D004347 | 1 | — | — | — | — | 1 | ||
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | — | — | — | — | 1 |
| Focal segmental glomerulosclerosis | D005923 | EFO_0004236 | 1 | — | — | — | — | 1 | |
| Erectile dysfunction | D007172 | EFO_0004234 | F52.21 | 1 | — | — | — | — | 1 |
Show 4 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Urinary bladder neoplasms | D001749 | C67 | — | — | — | — | 1 | 1 | |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | — | — | — | 1 | 1 |
| Carotid artery diseases | D002340 | EFO_0003781 | — | — | — | — | 1 | 1 | |
| Pituitary neoplasms | D010911 | — | — | — | — | 1 | 1 | ||
| Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | — | — | 1 | 1 |
| Chronic disease | D002908 | — | — | — | — | 1 | 1 | ||
| Dilated cardiomyopathy | D002311 | EFO_0000407 | I42.0 | — | — | — | — | 1 | 1 |
| Depression | D003863 | F33.9 | — | — | — | — | 1 | 1 | |
| Bipolar disorder | D001714 | EFO_0000289 | F30.9 | — | — | — | — | 1 | 1 |
| Diabetic nephropathies | D003928 | EFO_0000401 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | RUBIDIUM RB-82 |
| INN | — |
| Description | Cardiogen, Ruby-fill (rubidium rb-82) is a small molecule pharmaceutical. Rubidium rb-82 was first approved as Cardiogen-82 on 1989-12-29. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | [82Rb] |
Identifiers
| PDB | — |
| CAS-ID | 14391-63-0 |
| RxCUI | — |
| ChEMBL ID | CHEMBL4297424 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 86 documents
View more details
Safety
Black-box Warning
Black-box warning for:
ruby-fill, Cardiogen-82
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
111,563 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more